These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 19378355)

  • 1. Aspartic acid scaffold in bradykinin B1 antagonists.
    Huszár J; Timár Z; Bogár F; Penke B; Kiss R; Szalai KK; Schmidt E; Papp A; Keseru G
    J Pept Sci; 2009 Jun; 15(6):423-34. PubMed ID: 19378355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of dihydroquinoxalinone acetamides containing bicyclic amines as potent Bradykinin B1 receptor antagonists.
    Chen JJ; Qian W; Biswas K; Viswanadhan VN; Askew BC; Hitchcock S; Hungate RW; Arik L; Johnson E
    Bioorg Med Chem Lett; 2008 Aug; 18(16):4477-81. PubMed ID: 18674903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding modes of dihydroquinoxalinones in a homology model of bradykinin receptor 1.
    Ha SN; Hey PJ; Ransom RW; Harrell CM; Murphy KL; Chang R; Chen TB; Su DS; Markowitz MK; Bock MG; Freidinger RM; Hess FJ
    Biochem Biophys Res Commun; 2005 May; 331(1):159-66. PubMed ID: 15845373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual antagonists of the bradykinin B1 and B2 receptors based on a postulated common pharmacophore from existing non-peptide antagonists.
    Morissette G; Bouthillier J; Marceau F
    Biol Chem; 2006 Feb; 387(2):189-94. PubMed ID: 16497151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural modification of the highly potent peptide bradykinin B1 receptor antagonist B9958.
    Gera L; Stewart JM; Fortin JP; Morissette G; Marceau F
    Int Immunopharmacol; 2008 Feb; 8(2):289-92. PubMed ID: 18182242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potent nonpeptide antagonists of the bradykinin B1 receptor: structure-activity relationship studies with novel diaminochroman carboxamides.
    Biswas K; Li A; Chen JJ; D'Amico DC; Fotsch C; Han N; Human J; Liu Q; Norman MH; Riahi B; Yuan C; Suzuki H; Mareska DA; Zhan J; Clarke DE; Toro A; Groneberg RD; Burgess LE; Lester-Zeiner D; Biddlecome G; Manning BH; Arik L; Dong H; Huang M; Kamassah A; Loeloff R; Sun H; Hsieh FY; Kumar G; Ng GY; Hungate RW; Askew BC; Johnson E
    J Med Chem; 2007 May; 50(9):2200-12. PubMed ID: 17408249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of a potent, non-peptide bradykinin B1 receptor antagonist.
    Su DS; Markowitz MK; DiPardo RM; Murphy KL; Harrell CM; O'Malley SS; Ransom RW; Chang RS; Ha S; Hess FJ; Pettibone DJ; Mason GS; Boyce S; Freidinger RM; Bock MG
    J Am Chem Soc; 2003 Jun; 125(25):7516-7. PubMed ID: 12812482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Both B1R and B2R act as intermediate signaling molecules in high glucose-induced stimulation of glutamate uptake in ARPE cells.
    Lim SK; Han HJ; Kim KY; Park SH
    J Cell Physiol; 2009 Dec; 221(3):677-87. PubMed ID: 19725054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of the critical residues of bradykinin receptor B1 for interaction with the kinins guided by site-directed mutagenesis and molecular modeling.
    Ha SN; Hey PJ; Ransom RW; Bock MG; Su DS; Murphy KL; Chang R; Chen TB; Pettibone D; Hess JF
    Biochemistry; 2006 Dec; 45(48):14355-61. PubMed ID: 17128974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new class of bradykinin 1 receptor antagonists containing the piperidine acetic acid tetralin core.
    Fotsch C; Biddlecome G; Biswas K; Chen JJ; D'Amico DC; Groneberg RD; Han NB; Hsieh FY; Kamassah A; Kumar G; Lester-Zeiner D; Liu Q; Mareska DA; Riahi BB; Wang YJ; Yang K; Zhan J; Zhu J; Johnson E; Ng G; Askew BC
    Bioorg Med Chem Lett; 2006 Apr; 16(8):2071-5. PubMed ID: 16464576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative NMR and molecular dynamics study of the conformations of bradykinin B1 and B2, B2, and B1-specific receptor antagonists B-9430, B-9436, and B-9858.
    Sejbal J; Wang Y; Cann JR; Stewart JM; Gera L; Kotovych G
    Biopolymers; 1997 Oct; 42(5):521-35. PubMed ID: 9322442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation and characterization of a humanized bradykinin B1 receptor mouse.
    Hess JF; Chen RZ; Hey P; Breese R; Chang RS; Chen TB; Bock MG; Vogt T; Pettibone DJ
    Biol Chem; 2006 Feb; 387(2):195-201. PubMed ID: 16497152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2,3-Diaminopyridine as a platform for designing structurally unique nonpeptide bradykinin B1 receptor antagonists.
    Feng DM; Wai JM; Kuduk SD; Ng C; Murphy KL; Ransom RW; Reiss D; Chang RS; Harrell CM; MacNeil T; Tang C; Prueksaritanont T; Freidinger RM; Pettibone DJ; Bock MG
    Bioorg Med Chem Lett; 2005 May; 15(9):2385-8. PubMed ID: 15837330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aryl sulfonamides containing tetralin allylic amines as potent and selective bradykinin B1 receptor antagonists.
    Liu Q; Qian W; Li A; Biswas K; Chen JJ; Fotsch C; Han N; Yuan C; Arik L; Biddlecome G; Johnson E; Kumar G; Lester-Zeiner D; Ng GY; Hungate RW; Askew BC
    Bioorg Med Chem Lett; 2010 Aug; 20(15):4593-7. PubMed ID: 20573508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potent and orally bioavailable non-peptide antagonists at the human bradykinin B(1) receptor based on a 2-alkylamino-5-sulfamoylbenzamide core.
    Ritchie TJ; Dziadulewicz EK; Culshaw AJ; Müller W; Burgess GM; Bloomfield GC; Drake GS; Dunstan AR; Beattie D; Hughes GA; Ganju P; McIntyre P; Bevan SJ; Davis C; Yaqoob M
    J Med Chem; 2004 Sep; 47(19):4642-4. PubMed ID: 15341478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2-Aminobenzophenones as a novel class of bradykinin B1 receptor antagonists.
    Su DS; Lim JL; Tinney E; Wan BL; Murphy KL; Reiss DR; Harrell CM; O'Malley SS; Ransom RW; Chang RS; Pettibone DJ; Yu J; Tang C; Prueksaritanont T; Freidinger RM; Bock MG; Anthony NJ
    J Med Chem; 2008 Jul; 51(13):3946-52. PubMed ID: 18553956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and optimization of a series of 3-carboxamido-5-phenacylaminopyrazole bradykinin B1 receptor antagonists.
    Dressen D; Garofalo AW; Hawkinson J; Hom D; Jagodzinski J; Marugg JL; Neitzel ML; Pleiss MA; Szoke B; Tung JS; Wone DW; Wu J; Zhang H
    J Med Chem; 2007 Oct; 50(21):5161-7. PubMed ID: 17880055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sulfonamido-aryl ethers as bradykinin B1 receptor antagonists.
    Cole AG; Metzger A; Brescia MR; Qin LY; Appell KC; Brain CT; Hallett A; Ganju P; Denholm AA; Wareing JR; Ritchie TJ; Drake GM; Bevan SJ; MacGloinn A; McBryde A; Patel V; Oakley PJ; Nunez X; Gstach H; Schneider P; Baldwin JJ; Dolle RE; McDonald E; Henderson I
    Bioorg Med Chem Lett; 2009 Jan; 19(1):119-22. PubMed ID: 19014884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indazole derivatives as novel bradykinin B1 receptor antagonists.
    Bodmer-Narkevitch V; Anthony NJ; Cofre V; Jolly SM; Murphy KL; Ransom RW; Reiss DR; Tang C; Prueksaritanont T; Pettibone DJ; Bock MG; Kuduk SD
    Bioorg Med Chem Lett; 2010 Dec; 20(23):7011-4. PubMed ID: 20971001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel small molecule bradykinin B1 receptor antagonists. Part 2: 5-membered diaminoheterocycles.
    Zischinsky G; Stragies R; Schaudt M; Pfeifer JR; Gibson C; Locardi E; Scharn D; Richter U; Kalkhof H; Dinkel K; Schnatbaum K
    Bioorg Med Chem Lett; 2010 Feb; 20(3):1229-32. PubMed ID: 20015651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.